B
BINP
vs
S&P 500
S&P 500
Over the past 12 months, BINP has underperformed S&P 500, delivering a return of -90% compared to the S&P 500's +14% growth.
Stocks Performance
BINP vs S&P 500
Performance Gap
BINP vs S&P 500
Performance By Year
BINP vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Bionoid Pharma Inc
Glance View
Bionoid Pharma, Inc. operates as a medical device company. The company is headquartered in Huntington Beach, California. The company went IPO on 2007-06-25. The firm develops and markets medical devices and technologies for the orthopedic and pain management markets. The firm develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The firm sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.